SIGNIFICANT ACCOUNTING POLICIES - Summarizes of Reportable Segment's Financial Information (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||||||
| Segment Reporting Information [Line Items] | ||||||||||||
| Research and development expenses | $ 7,187,235 | $ 1,298,041 | $ 12,442,201 | $ 2,660,479 | ||||||||
| General and administrative expenses | 3,454,924 | 2,076,108 | 14,871,510 | 4,616,554 | ||||||||
| Total expenses | 10,642,159 | 3,374,149 | 27,313,711 | 7,277,033 | ||||||||
| Loss from operations | (10,642,159) | (3,374,149) | (27,313,711) | (7,277,033) | ||||||||
| Reconciling items: | ||||||||||||
| Foreign exchange losses | (14,351) | (21,110) | (16,155) | (29,486) | ||||||||
| Investment income | 569,591 | 136,671 | 1,199,193 | 294,959 | ||||||||
| Changes in fair value of the warrant liability | 27,553,204 | (81,807,426) | ||||||||||
| Net income (loss) | 17,466,285 | $ (125,404,384) | (3,258,588) | $ (3,752,972) | (107,938,099) | (7,011,560) | ||||||
| Operating Segments | ||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||
| Total | 9,290,119 | 2,409,629 | 24,123,813 | 4,909,900 | ||||||||
| Other segment expense, net | [1] | 1,352,040 | 964,520 | 3,189,898 | 2,367,133 | |||||||
| Total expenses | 10,642,159 | 3,374,149 | 27,313,711 | 7,277,033 | ||||||||
| Loss from operations | (10,642,159) | (3,374,149) | (27,313,711) | (7,277,033) | ||||||||
| Reconciling items: | ||||||||||||
| Foreign exchange losses | (14,351) | (21,110) | (16,155) | (29,486) | ||||||||
| Investment income | 569,591 | 136,671 | 1,199,193 | 294,959 | ||||||||
| Changes in fair value of the warrant liability | 27,553,204 | (81,807,426) | ||||||||||
| Net income (loss) | 17,466,285 | (3,258,588) | (107,938,099) | (7,011,560) | ||||||||
| Operating Segments | Staff Related Expenses | ||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||
| Research and development expenses | [2] | 508,065 | 447,397 | 1,018,294 | 913,388 | |||||||
| General and administrative expenses | [2] | 900,879 | 914,526 | 2,578,767 | 1,857,157 | |||||||
| Operating Segments | External Costs | ||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||
| Research and development expenses | [3] | 5,608,335 | 749,488 | 9,543,610 | 1,543,908 | |||||||
| Operating Segments | Stock Compensation Expenses (Non-cash) | ||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||
| Research and development expenses | 996,213 | 100,130 | 1,734,150 | 199,829 | ||||||||
| General and administrative expenses | $ 1,276,627 | $ 198,088 | $ 9,248,992 | $ 395,618 | ||||||||
| ||||||||||||
| X | ||||||||||
- Definition Reconciling items. No definition available.
|
| X | ||||||||||
- Definition Research and development and general and administrative expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|